US Stem Cell Inc (USRM)

[Xpecht]

Ultimately what makes this move up in the long run is the clear path from the FDA. Which according to Tomas hasn't been clear! FDA and USRM are in a power struggle from what I can see. The letter provides more clarity to the path (which should be turnkey to follow)and makes someone at the FDA feel like they are doing their "job". Clearly this employee didn't get the memo Gottlieb is the new sheriff in town. These are simply growing pains to get a breakthrough treatment to market USRM is here for the long run like it or not.

(All above are simply my humble opinions)